Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension

Hypertension

Volumn 30, Issue 5, 1997, Pages 1223-1231

  Feng, Jian J ^a   Arendshorst, William J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Arterioles; Calcium channels; Heparin; Nifedipine; Rats, inbred SHR; Renal circulation

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ARGIPRESSIN; CALCIUM; CALCIUM CHANNEL; HEPARIN; INOSITOL 1,4,5 TRISPHOSPHATE; NIFEDIPINE;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM MOBILIZATION; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030660271     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1223     Document Type: Article

References (38)

1. Rettig R, Schmitt B, Pelzl B, Speck T. The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens. 1993;11:883-891.
2. Dilley JR, Stier CT Jr, Arendshorst WJ. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol. 1984;246:F12-F20.
3. Chatziantoniou C, Daniels FH, Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol. 1990;259:F372-F382.
4. Chatziantoniou C, Arendshorst WJ. Impaired ability of prostaglandins to buffer renal vasoconstriciton in genetically hypertensive rats. Am J Physiol. 1992;263:F573-F580.
5. Chatziantoniou C, Ruan X, Arendshorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci U S A. 1995;92:2924-2928.
6. 1 receptors. Am J Physiol. 1996;271:F304-F313.
7. Schiffrin EL. Intracellular signal transduction for vasoactive peptides in hypertension. Can J Physiol Pharmacol. 1994;72: 954-962.
8. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986;233:305-312.
9. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 1984;312:315-321.
10. Bonventre JV, Skorecki KL, Kreisberg JI, Cheung JY. Vasopressin increases cytosolic free calcium concentration in glomerular mesangial cells. Am J Physiol. 1986;251:F94-F102.
11. Hassid A, Pidikiti N, Gamero D. Effects of vasoactive peptides on cytosolic calcium in cultured mesangial cells. Am J Physiol. 1986; 251:F1018-F1028.
12. Takeda K, Meyer-Lehnert H, Kim JK, Schrier RW. AVP-induced Ca fluxes and contraction of rat glomerular mesangial cells. Am J Physiol. 1988;255:F142-F150.
13. 2 in glomerular mesangial cells. J Lab Clin Med. 1992;120:752-761.
14. Vigne P, Breittmayer JP, Lazdunski M, Frelin C. The regulation of the cytoplasmic free Ca2+ concentration in aortic smooth muscle cells (A7r5 line) after stimulation by vasopressin and bombesin. Eur J Biochem. 1988;176:47-52.
15. Hughes AD, Schachter M. Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line (A7r5). Cell Calcium. 1994;15:317-330.
16. Nabika T, Velletri PA, Lovenberg W, Beaven MA. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [Arg] vasopressin in vascular smooth muscle cells. J Bio Chem. 1985;260:4661-4670.
17. 2+ oscillations by vasopressin in the presence of tetraethylammonium chloride in cultured vascular smooth muscle cells. J Biochem. 1995;117:309-314.
18. 2+ release in mammalian vascular smooth muscle cells. Am J Physiol. 1992;263:H576-H586.
19. Goldberg JP, Schrier RW. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin. Miner Electro Metab. 1984;10:178-183.
20. Seino M, Abe K, Tsunoda K, Yoshinaga K. Interaction of vasopressin and prostaglandins through calcium ion in the renal circulation. Hypertension. 1985;7:53-58.
21. 2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs. J Cardiovasc Pharmacol. 1990;16:966-970.
22. Xiong Z, Sperelakis N, Regulation of L-type calcium channels of vascular smooth muscle cells. J Mol Cell Cardiol. 1995;27:75-91.
23. Ogawa N, Ono H. Effect of 8-(N,N-diethylaminl)octyl-3,4,5-trimetoxybenzoate (TMB-8), an inhibitor of intracellular Ca2+ release, on autoregulation of renal blood flow in the dog. Naunyn Schmiedeberg Arch Pharmacol. 1988;338:293-296.
24. Chiou CY, Malagodi MH. Studies on the mechanisms of action of a new Ca2+ antagonist, 8-(N,N-diethylamino)octyl-3,4,5,-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol. 1978;53:279-285.
25. Kobayashi S, Somlyo AV, Somlyo AP. Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem Biophys Res Commun. 1988;153:625-631.
26. Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL. Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J Biol Chem. 1988;263:11075-11079.
27. Cooper CL, Malik KU. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther. 1984;229:139-147.
28. Jelicks LA, Gupta RK. NMR measurement of cytosolic free calcium, free magnesium, and intracellular sodium in the aorta of the normal and spontaneously hypertensive rat. J Biol Chem. 1990; 265:1394-1400.
29. Bhalla RC, Webb RC, Singh D, Ashley T, Brock T. Calcium fluxes, calcium binding, and adenosine cyclic 3′,5′-monophosphate-dependent protein kinase activity in the aorta of spontaneously hypertensive and Kyoto Wistar normotensive rats. Mol Pharmacol. 1978;14:468-477.
30. Nabika T, Velletri PA, Beaven MA, Endo J, Lovenberg W. Vasopressin-induced calcium increases in smooth muscle cells from spontaneously hypertensive rats. Life Sci. 1985;37:579-584.
31. Yamada K, Goto A, Matsuoka H, Sugimoto T. Alterations of calcium channels in vascular smooth muscle cells from spontaneously hypertensive rats. Jpn Heart J. 1992;33:727-734.
32. Bund SJ, Heagerty AM, Aalkjaer C, Swales JD. Vasopressin-mediated contractions in mesenteric arteries from spontaneously hypertensive rats: differences in response compared with Wistar-Kyoto animals. Clin Sci. 1988;75:449-453.
33. Vallotton MB, Wuthrich RP, Lew PD, Capponi AM. Effects of vasopressin and its analogs on rat aortic smooth muscle and renal medullary tubular cells: characterization of receptor subtypes. J Cardiovasc Pharmacol. 1986;8(suppl):S5-11.
34. 2+ influx stimulated by vasopressin is mediated by phosphoinositide hydrolysis in rat smooth muscle cells. Biochem Biophys Res Commun. 1989;161: 677-682.
35. Capponi AM, Lew PD, Vallotton MB. Cytosolic free calcium levels in monolayers of cultured rat aortic smooth muscle cells: effects of angiotensin II and vasopressin. J Biol Chem. 1985;260:7836-7842.
36. Doyle VM, Ruegg UT. Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun, 1985;131:469-476.
37. Aiyar N, Nambi P, Stassen FL, Crooke ST. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci. 1986;39:37-45.
38. Ruan X, Arendshorst WJ. Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo. Am J Physiol. 1996;270:F398-F405.